Terms ending in 2031
Every in-force patent on Codexis, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,394,551 | Processes Using Amino Acid Dehydrogenases and Ketoreductase-Based Cofactor Regenerating System In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 9,714,439 | Processes Using Amino Acid Dehydrogenases and Ketoreductase-Based Cofactor Regenerating System In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 10,196,667 | Processes Using Amino Acid Dehydrogenases and Ketoreductase-Based Cofactor Regenerating System In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 10,604,781 | Processes Using Amino Acid Dehydrogenases and Ketoreductase-Based Cofactor Regenerating System In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 11,193,157 | Processes Using Amino Acid Dehydrogenases and Ketoreductase-Based Cofactor Regenerating System In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 8,470,564 | Transaminase Polypeptides In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 8,247,192 | Penicillin-G Acylases In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 9,388,391 | Biocatalysts for Ezetimibe Synthesis In force · High confidence | Codexis Inc. | In force | High confidence | |
| US 9,644,189 | Biocatalysts for Ezetimibe Synthesis In force · Medium confidence | Codexis Inc. | In force | Medium confidence | |
| US 10,053,673 | Biocatalysts for Ezetimibe Synthesis In force · Low confidence | Codexis Inc. | In force | Low confidence | |
| 17 more term ends in 2031 · Pro | |||||
10 of 27 patents shown. Soonest term end first, then patent number.
Pro members see all 27.
25 of these are in force and held by Codexis, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.